208 related articles for article (PubMed ID: 33168727)
1. REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks.
Chatterjee N; Whitman MA; Harris CA; Min SM; Jonas O; Lien EC; Luengo A; Vander Heiden MG; Hong J; Zhou P; Hemann MT; Walker GC
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28918-28921. PubMed ID: 33168727
[TBL] [Abstract][Full Text] [Related]
2. A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.
Wojtaszek JL; Chatterjee N; Najeeb J; Ramos A; Lee M; Bian K; Xue JY; Fenton BA; Park H; Li D; Hemann MT; Hong J; Walker GC; Zhou P
Cell; 2019 Jun; 178(1):152-159.e11. PubMed ID: 31178121
[TBL] [Abstract][Full Text] [Related]
3. REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
Taglialatela A; Leuzzi G; Sannino V; Cuella-Martin R; Huang JW; Wu-Baer F; Baer R; Costanzo V; Ciccia A
Mol Cell; 2021 Oct; 81(19):4008-4025.e7. PubMed ID: 34508659
[TBL] [Abstract][Full Text] [Related]
4. Implications of inhibition of Rev1 interaction with Y family DNA polymerases for cisplatin chemotherapy.
Yoon JH; Johnson RE; Prakash L; Prakash S
Genes Dev; 2021 Sep; 35(17-18):1256-1270. PubMed ID: 34385260
[TBL] [Abstract][Full Text] [Related]
5. Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.
Hicks JK; Chute CL; Paulsen MT; Ragland RL; Howlett NG; Guéranger Q; Glover TW; Canman CE
Mol Cell Biol; 2010 Mar; 30(5):1217-30. PubMed ID: 20028736
[TBL] [Abstract][Full Text] [Related]
6. Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.
Sail V; Rizzo AA; Chatterjee N; Dash RC; Ozen Z; Walker GC; Korzhnev DM; Hadden MK
ACS Chem Biol; 2017 Jul; 12(7):1903-1912. PubMed ID: 28541665
[TBL] [Abstract][Full Text] [Related]
7. The vital role of polymerase ζ and REV1 in mutagenic, but not correct, DNA synthesis across benzo[a]pyrene-dG and recruitment of polymerase ζ by REV1 to replication-stalled site.
Hashimoto K; Cho Y; Yang IY; Akagi J; Ohashi E; Tateishi S; de Wind N; Hanaoka F; Ohmori H; Moriya M
J Biol Chem; 2012 Mar; 287(12):9613-22. PubMed ID: 22303021
[TBL] [Abstract][Full Text] [Related]
8. Rev1 promotes replication through UV lesions in conjunction with DNA polymerases η, ι, and κ but not DNA polymerase ζ.
Yoon JH; Park J; Conde J; Wakamiya M; Prakash L; Prakash S
Genes Dev; 2015 Dec; 29(24):2588-602. PubMed ID: 26680302
[TBL] [Abstract][Full Text] [Related]
9. Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion Synthesis.
Pustovalova Y; Magalhães MT; D'Souza S; Rizzo AA; Korza G; Walker GC; Korzhnev DM
Biochemistry; 2016 Apr; 55(13):2043-53. PubMed ID: 26982350
[TBL] [Abstract][Full Text] [Related]
10. Rev7 dimerization is important for assembly and function of the Rev1/Polζ translesion synthesis complex.
Rizzo AA; Vassel FM; Chatterjee N; D'Souza S; Li Y; Hao B; Hemann MT; Walker GC; Korzhnev DM
Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8191-E8200. PubMed ID: 30111544
[TBL] [Abstract][Full Text] [Related]
11. DNA polymerase ζ is a major determinant of resistance to platinum-based chemotherapeutic agents.
Sharma S; Shah NA; Joiner AM; Roberts KH; Canman CE
Mol Pharmacol; 2012 Jun; 81(6):778-87. PubMed ID: 22387291
[TBL] [Abstract][Full Text] [Related]
12. Roles of mutagenic translesion synthesis in mammalian genome stability, health and disease.
Jansen JG; Tsaalbi-Shtylik A; de Wind N
DNA Repair (Amst); 2015 May; 29():56-64. PubMed ID: 25655219
[TBL] [Abstract][Full Text] [Related]
13. Translesion synthesis of acetylaminofluorene-dG adducts by DNA polymerase zeta is stimulated by yeast Rev1 protein.
Guo D; Xie Z; Shen H; Zhao B; Wang Z
Nucleic Acids Res; 2004; 32(3):1122-30. PubMed ID: 14960722
[TBL] [Abstract][Full Text] [Related]
14. Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage.
Pernicone N; Elias M; Onn I; Tobi D; Listovsky T
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163901
[TBL] [Abstract][Full Text] [Related]
15. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation.
Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM
Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884
[TBL] [Abstract][Full Text] [Related]
16. Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer.
Vassel FM; Bian K; Walker GC; Hemann MT
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28922-28924. PubMed ID: 33144509
[TBL] [Abstract][Full Text] [Related]
17. Interaction with DNA polymerase eta is required for nuclear accumulation of REV1 and suppression of spontaneous mutations in human cells.
Akagi J; Masutani C; Kataoka Y; Kan T; Ohashi E; Mori T; Ohmori H; Hanaoka F
DNA Repair (Amst); 2009 May; 8(5):585-99. PubMed ID: 19157994
[TBL] [Abstract][Full Text] [Related]
18. The non-canonical protein binding site at the monomer-monomer interface of yeast proliferating cell nuclear antigen (PCNA) regulates the Rev1-PCNA interaction and Polζ/Rev1-dependent translesion DNA synthesis.
Sharma NM; Kochenova OV; Shcherbakova PV
J Biol Chem; 2011 Sep; 286(38):33557-66. PubMed ID: 21799021
[TBL] [Abstract][Full Text] [Related]
19. REV1 and polymerase ζ facilitate homologous recombination repair.
Sharma S; Hicks JK; Chute CL; Brennan JR; Ahn JY; Glover TW; Canman CE
Nucleic Acids Res; 2012 Jan; 40(2):682-91. PubMed ID: 21926160
[TBL] [Abstract][Full Text] [Related]
20. Error-prone translesion synthesis mediates acquired chemoresistance.
Xie K; Doles J; Hemann MT; Walker GC
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20792-7. PubMed ID: 21068378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
